These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 6336775

  • 1. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
    Russell PS, Chase CM, Burton RC.
    J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
    [Abstract] [Full Text] [Related]

  • 2. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
    McIntosh JK, Mulé JJ, Travis WD, Rosenberg SA.
    Cancer Res; 1990 Apr 15; 50(8):2463-9. PubMed ID: 2317830
    [Abstract] [Full Text] [Related]

  • 3. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM, Capel PJ, Koene RA.
    J Immunol; 1980 Feb 15; 124(2):719-23. PubMed ID: 6985936
    [Abstract] [Full Text] [Related]

  • 4. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
    Livingston PO, Jones M, Deleo AB, Oettgen HF, Old LJ.
    J Immunol; 1985 Aug 15; 135(2):1505-9. PubMed ID: 4008930
    [Abstract] [Full Text] [Related]

  • 5. Further observations on the effect of cyclophosphamide on intratumor and peripheral leukocyte levels.
    Evans R.
    Am J Pathol; 1980 Jun 15; 99(3):667-84. PubMed ID: 7386598
    [Abstract] [Full Text] [Related]

  • 6. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment.
    Reichert CM, Rosenstein M, Von Glatz J, Hsu SM, Rosenberg SA.
    Lab Invest; 1985 Mar 15; 52(3):304-13. PubMed ID: 3974201
    [Abstract] [Full Text] [Related]

  • 7. Effect of cyclophosphamide on mice bearing methylcholanthrene-induced fibrosarcomas.
    Yu S, Lannin DR, Tsui-Collins AL, McKhann CF.
    Cancer Res; 1980 Aug 15; 40(8 Pt 1):2756-61. PubMed ID: 7388826
    [Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI, Fuller JA, Kremlev SG, Kamdar SJ, Evans R.
    J Immunol; 1998 Dec 15; 161(12):6977-84. PubMed ID: 9862733
    [Abstract] [Full Text] [Related]

  • 9. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H, Chilton PM, Huang Y, Schanie CL, Yan J, Ildstad ST.
    Transplantation; 2007 Apr 15; 83(7):954-63. PubMed ID: 17460568
    [Abstract] [Full Text] [Related]

  • 10. Antigenic requirement for induced rejection of long-surviving murine heart transplants.
    Burdick JF, Russell PS.
    J Immunol; 1982 Apr 15; 128(4):1551-4. PubMed ID: 7037951
    [Abstract] [Full Text] [Related]

  • 11. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
    Nomoto K, Yung-Yun K, Omoto K, Umesue M, Murakami Y, Matsuzaki G, Nomoto K.
    Transplantation; 1995 Feb 15; 59(3):395-401. PubMed ID: 7871570
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
    Kanwar JR, Kanwar RK, Pandey S, Ching LM, Krissansen GW.
    Cancer Res; 2001 Mar 01; 61(5):1948-56. PubMed ID: 11280751
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Strain differences in the antitumor activity of an immunopotentiator, Nocardia rubra cell-wall skeleton, in B10 congenic and recombinant mice.
    Haraguchi S, Kurakata S, Matsuo T, Yoshida TO.
    Jpn J Cancer Res; 1985 May 01; 76(5):400-13. PubMed ID: 2989065
    [Abstract] [Full Text] [Related]

  • 18. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF, Inoue Y, Miyazaki D, Hara Y, Shimomura Y, Tano Y, Ohashi Y.
    Invest Ophthalmol Vis Sci; 1997 Feb 01; 38(2):292-300. PubMed ID: 9040461
    [Abstract] [Full Text] [Related]

  • 19. Functional heterogeneity of Sarcoma I cells in transplantation experiments.
    Sobotková E, Sůla K, Nouza K.
    Neoplasma; 1990 Feb 01; 37(2):139-47. PubMed ID: 2342629
    [Abstract] [Full Text] [Related]

  • 20. Study of destructive mechanisms of the immune response to sarcoma I allograft in mice.
    Vidrnová M, Nouza K, Nĕmec M.
    Neoplasma; 1984 Feb 01; 31(4):369-80. PubMed ID: 6472512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.